## NDAQ: Nasdaq, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 1.40 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($86.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is Phillips 66 Stock Underperforming the Nasdaq?**
- Source: MSN | 20251201T142144 | Neutral | Relevance: 86%
- This article examines whether Phillips 66 (PSX) stock is underperforming the Nasdaq, focusing on recent stock performance and key financial metrics. It highlights PSX's total return of 18.06% over the past year compared to the Nasdaq's 29.56% but notes PSX's strong dividend yield and valuation advantages. The piece concludes by suggesting PSX could offer better value for discerning investors despite its relative underperformance against the broader market index.

**2. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20251201T170200 | Neutral | Relevance: 64%
-  JPMorgan Chase Financial Company LLC is issuing $4,811,000 Callable Contingent Interest Notes, fully and unconditionally guaranteed by JPMorgan Chase & Co. These notes are linked to the performance of the Nasdaq-100 Technology Sector Index, Russell 2000 Index, and S&P 500 Index, offering contingent interest payments based on the indices' performance against specified barriers. The notes feature a potential early redemption option and entail risks including loss of principal and non-payment of interest if specific market conditions are not met.

**3. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20251201T184200 | Neutral | Relevance: 64%
- JPMorgan Chase Financial Company LLC is offering $250,000 Capped Buffered Equity Notes linked to the Nasdaq-100 Index, fully and unconditionally guaranteed by JPMorgan Chase & Co. These notes offer a return of 1.00 times appreciation up to 50.00% at maturity, but investors risk losing up to 90.00% of their principal. The offering details include pricing, settlement dates, and significant risk considerations for potential investors.

**4. Prestige Wealth completes rebranding to Aurelion, begins trading on Nasdaq**
- Source: Investing.com | 20251201T043410 | Somewhat-Bullish | Relevance: 61%
-  Prestige Wealth Inc. has rebranded to Aurelion Inc. and is now trading on Nasdaq under the ticker NASDAQ:AURE. This change follows a $100 million PIPE transaction and a $50 million debt facility, which allowed the company to acquire $134 million of Tether Gold, positioning itself as a "Tether Gold Real World Asset (RWA) company." Aurelion plans to focus on tokenized gold business opportunities while continuing its wealth and asset management services.

**5. Cocrystal Pharma to Present at the Noble Capital Marketsâ€™ 21st Emerging Growth Equity Conference**
- Source: GlobeNewswire | 20251201T080000 | Neutral | Relevance: 61%
-  Cocrystal Pharma, Inc. (Nasdaq: COCP) announced that James Martin, CFO and co-CEO, will present a company overview and clinical progress update at Noble Capital Markets' 21st Emerging Growth Equity Conference on December 3, 2025. The presentation will cover the company's innovative antiviral treatments for various challenging diseases. A webcast of the presentation will be available online one day after the live event.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Morgan Stanley | $110 | $97 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Morgan Stanley | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+6.9%)
- Investor AB: 10.2% (0.0%)
- Blackrock Inc.: 7.0% (+8.3%)
- Wellington Managemen: 7.0% (-3.5%)
- Massachusetts Financ: 4.6% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.40 suggests fair value with growth premium. Forward P/E 23.4x stretched relative to 11% growth. Quality metrics strong (margin 20%). Analyst sentiment positive (1 raises, avg +13%). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $52.7B |
| Beta | 1.02 |
| 52W Range | $64.84 - $97.63 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.40 |
| Forward P/E | 23.4 |
| Current P/E | 26.1 |
| YoY Growth | 11.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.9% to -0.6% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.59% (CS: 52) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | 0.48 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 1.047x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $89.36
- **Stop Loss:** $86.24 (3.5% risk)
- **Target:** $92.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 320
- **Position Value:** $28,595.20
- **Portfolio %:** 28.60%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-28 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.88 | +3.7% |
| 2025Q2 | $0.81 | $0.85 | +4.6% |
| 2025Q1 | $0.77 | $0.79 | +2.5% |
| 2024Q4 | $0.75 | $0.76 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*